STERIS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 202.8 USD | -1.55% |
|
+1.28% | -7.76% |
| Apr. 19 | Wolfe Research Adjusts STERIS Price Target to $235 From $245 | MT |
| Apr. 11 | Sector Update: Health Care Stocks Steady Pre-Bell Thursday | MT |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 37.62 times its estimated earnings per share for the ongoing year.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -7.76% | 20.35B | B- | ||
| -2.89% | 187B | C+ | ||
| -2.43% | 108B | C | ||
| -4.10% | 67.71B | A | ||
| +11.10% | 53.07B | B- | ||
| +15.86% | 47.36B | B- | ||
| +3.91% | 39.73B | B+ | ||
| +9.55% | 28.56B | A- | ||
| +1.85% | 26.55B | B | ||
| +14.24% | 25.13B | A- |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- STE Stock
- Ratings STERIS plc
